150 related articles for article (PubMed ID: 31643059)
1. High-Resolution Characterization of ADCs by Orbitrap LCMS.
He J; Kaur S; Xu K
Methods Mol Biol; 2020; 2078():213-219. PubMed ID: 31643059
[TBL] [Abstract][Full Text] [Related]
2. High-Resolution Accurate-Mass Mass Spectrometry Enabling In-Depth Characterization of in Vivo Biotransformations for Intact Antibody-Drug Conjugates.
He J; Su D; Ng C; Liu L; Yu SF; Pillow TH; Del Rosario G; Darwish M; Lee BC; Ohri R; Zhou H; Wang X; Lu J; Kaur S; Xu K
Anal Chem; 2017 May; 89(10):5476-5483. PubMed ID: 28429938
[TBL] [Abstract][Full Text] [Related]
3. Custom-Designed Affinity Capture LC-MS F(ab')2 Assay for Biotransformation Assessment of Site-Specific Antibody Drug Conjugates.
Su D; Ng C; Khosraviani M; Yu SF; Cosino E; Kaur S; Xu K
Anal Chem; 2016 Dec; 88(23):11340-11346. PubMed ID: 27779866
[TBL] [Abstract][Full Text] [Related]
4. Two-Dimensional Liquid Chromatography Coupled to High-Resolution Mass Spectrometry for the Analysis of ADCs.
Chapel S; Rouvière F; Sarrut M; Heinisch S
Methods Mol Biol; 2020; 2078():163-185. PubMed ID: 31643056
[TBL] [Abstract][Full Text] [Related]
5. [The Characterization of Drug-to-Antibody Ratio and Isoforms of ADCs Using LC and MS Technologies].
Iizuka R; Kotch F; Xu A; Porter T; Shion H; Birdsall R; Chen W
Yakugaku Zasshi; 2017; 137(5):525-528. PubMed ID: 28458283
[TBL] [Abstract][Full Text] [Related]
6. Practical approaches for overcoming challenges in heightened characterization of antibody-drug conjugates with new methodologies and ultrahigh-resolution mass spectrometry.
Friese OV; Smith JN; Brown PW; Rouse JC
MAbs; 2018 Apr; 10(3):335-345. PubMed ID: 29393747
[TBL] [Abstract][Full Text] [Related]
7. Analysis of antibody-drug conjugates by comprehensive on-line two-dimensional hydrophobic interaction chromatography x reversed phase liquid chromatography hyphenated to high resolution mass spectrometry. I - Optimization of separation conditions.
Sarrut M; Corgier A; Fekete S; Guillarme D; Lascoux D; Janin-Bussat MC; Beck A; Heinisch S
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Oct; 1032():103-111. PubMed ID: 27426266
[TBL] [Abstract][Full Text] [Related]
8. Analysis of ADCs by Native Mass Spectrometry.
Hernandez-Alba O; Ehkirch A; Beck A; Cianférani S
Methods Mol Biol; 2020; 2078():197-211. PubMed ID: 31643058
[TBL] [Abstract][Full Text] [Related]
9. Qualitative analysis of antibody-drug conjugates (ADCs): an experimental comparison of analytical techniques of cysteine-linked ADCs.
Källsten M; Hartmann R; Artemenko K; Lind SB; Lehmann F; Bergquist J
Analyst; 2018 Nov; 143(22):5487-5496. PubMed ID: 30289422
[TBL] [Abstract][Full Text] [Related]
10. Characterization of Antibody-Drug Conjugate Pharmacokinetics and in Vivo Biotransformation Using Quantitative Intact LC-HRMS and Surrogate Analyte LC-MRM.
Huang Y; Mou S; Wang Y; Mu R; Liang M; Rosenbaum AI
Anal Chem; 2021 Apr; 93(15):6135-6144. PubMed ID: 33835773
[TBL] [Abstract][Full Text] [Related]
11. Native-MS Analysis of Monoclonal Antibody Conjugates by Fourier Transform Ion Cyclotron Resonance Mass Spectrometry.
Campuzano IDG; Netirojjanakul C; Nshanian M; Lippens JL; Kilgour DPA; Van Orden S; Loo JA
Anal Chem; 2018 Jan; 90(1):745-751. PubMed ID: 29193956
[TBL] [Abstract][Full Text] [Related]
12. Analysis of antibody-drug conjugates by comprehensive on-line two-dimensional hydrophobic interaction chromatography x reversed phase liquid chromatography hyphenated to high resolution mass spectrometry. II- Identification of sub-units for the characterization of even and odd load drug species.
Sarrut M; Fekete S; Janin-Bussat MC; Colas O; Guillarme D; Beck A; Heinisch S
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Oct; 1032():91-102. PubMed ID: 27426265
[TBL] [Abstract][Full Text] [Related]
13. Utility of Ion Mobility Mass Spectrometry for Drug-to-Antibody Ratio Measurements in Antibody-Drug Conjugates.
Huang RY; Deyanova EG; Passmore D; Rangan V; Deshpande S; Tymiak AA; Chen G
J Am Soc Mass Spectrom; 2015 Oct; 26(10):1791-4. PubMed ID: 26122520
[TBL] [Abstract][Full Text] [Related]
14. Characterization of an antibody-drug conjugate by hydrophilic interaction chromatography coupled to mass spectrometry.
D'Atri V; Fekete S; Stoll D; Lauber M; Beck A; Guillarme D
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Mar; 1080():37-41. PubMed ID: 29477065
[TBL] [Abstract][Full Text] [Related]
15. An enzymatic deconjugation method for the analysis of small molecule active drugs on antibody-drug conjugates.
Li Y; Gu C; Gruenhagen J; Yehl P; Chetwyn NP; Medley CD
MAbs; 2016; 8(4):698-705. PubMed ID: 26891281
[TBL] [Abstract][Full Text] [Related]
16. Universal Affinity Capture Liquid Chromatography-Mass Spectrometry Assay for Evaluation of Biotransformation of Site-Specific Antibody Drug Conjugates in Preclinical Studies.
Kotapati S; Passmore D; Yamazoe S; Sanku RKK; Cong Q; Poudel YB; Chowdari NS; Gangwar S; Rao C; Rangan VS; Cardarelli PM; Deshpande S; Strop P; Dollinger G; Rajpal A
Anal Chem; 2020 Jan; 92(2):2065-2073. PubMed ID: 31860282
[TBL] [Abstract][Full Text] [Related]
17. Automated high-throughput buffer exchange platform enhances rapid flow analysis of antibody drug conjugates by high resolution mass spectrometry.
Yang Y; Rao R; Valliere-Douglass J; Tremintin G
J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Mar; 1235():124007. PubMed ID: 38387340
[TBL] [Abstract][Full Text] [Related]
18. Application of triple quadrupole mass spectrometry for the characterization of antibody-drug conjugates.
Källsten M; Pijnappel M; Hartmann R; Lehmann F; Kovac L; Lind SB; Bergquist J
Anal Bioanal Chem; 2019 May; 411(12):2569-2576. PubMed ID: 30848315
[TBL] [Abstract][Full Text] [Related]
19. Innovative native MS methodologies for antibody drug conjugate characterization: High resolution native MS and IM-MS for average DAR and DAR distribution assessment.
Debaene F; Boeuf A; Wagner-Rousset E; Colas O; Ayoub D; Corvaïa N; Van Dorsselaer A; Beck A; Cianférani S
Anal Chem; 2014 Nov; 86(21):10674-83. PubMed ID: 25270580
[TBL] [Abstract][Full Text] [Related]
20. Insights from native mass spectrometry approaches for top- and middle- level characterization of site-specific antibody-drug conjugates.
Botzanowski T; Erb S; Hernandez-Alba O; Ehkirch A; Colas O; Wagner-Rousset E; Rabuka D; Beck A; Drake PM; Cianférani S
MAbs; 2017 Jul; 9(5):801-811. PubMed ID: 28406343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
